26.02.2018 • NewsDede WillamsLanxessMacrolex

Lanxess Lifts Macrolex Dyes Output

German specialty chemicals producer Lanxess is spending €5 million on a 25%...
German specialty chemicals producer Lanxess is spending €5 million on a 25% capacity expansion its Macrolex-brand dyes at its Leverkusen site

German specialty chemicals producer Lanxess is spending €5 million on a 25% capacity expansion its Macrolex-brand dyes at its Leverkusen site. The upgrade is expected to be completed by the end of this year.

The company said the investment is in response to a “significant” rise in demand for high quality dyes. Much of thid increase is being seen in Asia, said Philipp Junge, head of Lanxess’s Rhein Chemie business unit.

The soluble, organic dyes of are used primarily to color high-quality plastic products such as polystyrene (PS), polycarbonate (PC), acrylonitrile butadiene styrene (ABS), polymethyl methacrylate (PMMA) and polyethylene terephthalate (PET).

Dominik Risse, who is responsible for the colorant additives business at the Cologne-based company, added that stricter regulatory requirements also play a role. Especially in sensitive areas of application, particularly pure products, for which Lanxess claims market leader leadership more and more of the dyes are needed.

Risse said the capacity expansion also represents “a clear commitment to the Leverkusen site, where, along with capacity, jobs are being added.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.